IMS site is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
22 - 24 September 2021
Vice President- Global IP HeadIntas Pharmaceuticals Ltd.
General Manager - Global IPZydus Cadila
Chief IP Counsel - Global Head IPRBiocon
General Manager - Global IPZydus Cadilla
Sr.Vice President Legal and Group GCWockhardt
Head - IPM & Patent CounselUnichem Laboratories Limited
Chairperson, Fifth Board of AppealEuropean Union Intellectual Property Office
General Manager & Head - Global IP, Product Portfolio and Corporate StrategyPanacea Biotec
Vice President - IPMGlenmark Pharmaceuticals
Sr. GM - IPR LegalMylan Laboratory
Director LegalAbbott Healthcare
Sr. GM - IP SpecialityAurobindo
IPR departmentDr.Reddy’s Laboratories Ltd.
Sr. Director & Head-Business DevelopmentPortfolio & Strategy at Kashiv BioSciences LLC
Ph.D., Esq. PartnerGreenblum & Bernstein, P.L.C., USA
Director (Head) - Intellectual Property ManagementFresenius Kabi Oncology Ltd
General CounselMankind Pharma Limited
Head IP - Product PortfolioHikal Ltd
Sr. General Manager & Head – Corporate IPPiramal Pharma Global
Senior IP ConsultantIndoco Remedies Ltd
Vice Prresident and Head Portfolio Planning and IP LitigtaionSun Pharma
A.V.P. – IPMHetero Labs Ltd.
Vice President- Global IP Head
Intas Pharmaceuticals Ltd.
Dr. Alpesh Pathak is currently Vice President - Global IP Head at Intas Pharmaceuticals Ltd.
Dr. Alpesh has also written two books Entitled “Protecting Patent Fundamentals” and “Understanding Global patent litigations through landmark judgements – A litigation ready reckoner” which is well appreciated in patent professionals and major universities wherein patent is one of the value-added subject in the respective technical discipline. The second book is just published.
Dr. Alpesh Pathak has received an international award for the Top 50 In-house counsel in Singapore and also received several other awards for his contribution in the field of Intellectual Property since last more than two decades.
Having spent more than two decade in the field of IP, he works on a variety of intellectual property matters at Intas at Global Level, including IP due diligence of Biosimilar, IP activities for 351(k) filing, FTF Para IV filing, handling patent litigations across the globe and related activities, drafting and prosecution of patent applications, drafting and negotiation of intellectual property agreements with third parties, and due diligence analyses in supporting in-licensing and out-licensing activities.
Prior to joining Intas, Dr. Alpesh has worked with some of the leading pharmaceutical companies like Alembic Ltd, Lupin Ltd., Zydus Cadila and Cadila Pharmaceuticals. Alpesh holds a PhD degree from The Sardar Patel University. Dr. Alpesh Pathak is a registered Patent agent. Besides having PG diploma in Patent Law degree from Nalsar Uni, Hyderabad, he has undergone various specialized courses on US litigations and European patent practices. He has completed Masters from the Sardar Patel University, and a B.Sc. from the Same University with specialization in organic chemistry. Dr. Alpesh is also active in certain knowledge development programs for creating IP awareness by conducting lectures in various universities and conferences in India and abroad. He also currently a visiting faculty at Sardar Patel University and Gujarat Technical University (GTU).
Dr. Alpesh Pathak has contributed as speaker in more than 90 leading IP conferences/Seminars/workshop across the globe.
General Manager - Global IP
Chief IP Counsel - Global Head IPR
Arshad Jamil is a senior Indian Patent Attorney with extensive experience in the legal and IP rights fields. Arshad is the Chief IP counsel and Global head of IP rights at Biocon Biologics, where he is responsible for the Biocon Group’s patent and trademark filings and policy, and handling Global litigation for Biosimilarsand ANDAs . Arshad manages Biocon group of companies IP portfolio of 1100+ global patents and 950+ global trademarks.
In his previous assignment,Arshad was a Senior Patent Attorney at Sun Pharma, where he handled ANDA litigations, including Hatch Waxman settlements. He received his Bachelor of engineering (B.E.) from Mysore University in 1991 and his Bachelor of Laws(LL.B.) from Meerut (CCS) University in 1998. In 2014 he completed the SP Jain Institute of Management and Research postgraduate executive management programme.Arshad is a distinguished speaker at National /International IP forums and recognised by IAM as The World’s leading IP strategists consecutively for 4 years 2017 ,2018, 2019, and 2020 editions of IAM strategy 300.
Having more than 15 years of experience in the field of IntellectualProperty Rights (IPR) - especially Patents - associated withPharmaceutical formulation aspects.
Working on various IP aspects like:
Sr.Vice President Legal and Group GC
Ms. Debolina Partap, Sr.Vice President Legal and Group GC, Wockhardt, is a Gold Medalist in masters of law and has 28 years of experience in banking, finance, pharma and healthcare. She is responsible for all corporate legal work, M&As, IP and Litigation Management, legal compliance, transactions management amongst others. She advises top management on legal risks to the organization. She has contributed tremendously to Covid 19 vaccine contracts. Her main achievements come in settling complex financial cases and arbitrations filed against Wockhardt Limited, complex multi-jurisdictional arbitrations on commercial disputes and settling intricate derivatives suits filed against Wockhardt group globally. She is also handling legal issues pertaining to complex and composite global regulatory matters concerning Wockhardt Group. She is one of the few general counsels globally who handle forensics and data analytics. She and her team have won over 100 awards from internationally and nationally recognized legal organizations.
Head - IPM & Patent Counsel
Unichem Laboratories Limited
Mr. Gautam Bakshi, is an IP Attorney, currently working asHEAD - Intellectual Property Management & Patent Counsel with an Indian Multinational Pharmaceutical Company,Unichem Laboratories Limited.
Gautam is an experienced Intellectual Property Management professional with a demonstrated history of working in the Management position in the Pharmaceutical industry with proven track record. Skilled in Strategy, Management & Enforcement of IP coupled with strong Leadership capabilities nurtured with Management Development Programmes focused in Leadership Excellence from Top B-schools like Indian Institute of Management (IIM-C), XLRI & MDI.
He has rich expertise in the field of IP. His main areas of interest include Identification, Analysis and Management of IP. He is also well versed with the art and skill of IP Prosecution, Litigation. Licensing, Settlements and subsequent procedures thereof.
He has previously worked as Head IP for:
He was also associated in past with Dr. Reddy's Laboratories & Torrent Pharma.
Mr. Bakshi holds a Masters Degree in Pharmaceutical Sciences (M. Pharmacy) as well as Masters Degree in Business & Corporate Laws (LL.M.) alongwith several certifications/degrees/diplomas in IP.
He has several Patent Applications as an inventor to his credit filed globally. He has number of publications, has been Guest Faculty for many Institutes,been a panelist and an expert speaker in large number of seminars and workshops on IP rights and education, in India and overseas organized by:
Geoff Hussey is a Partner and Solicitor whose practice areas are IP litigation and commercial IP. His experience includes acting for a broad range of clients in many sectors including pharmaceuticals and biotechnology (where he has natural focus as a result of his technical background), chemicals, electronics, telecoms, aviation, food & beverages and financial services.
Geoff has extensive experience in patent litigation before the UK Patents Court, Court of Appeal, and in EPO patent oppositions concerning pharmaceuticals and medical devices including the coordination of parallel proceedings across many jurisdictions in Europe and the US. Geoff’s contentious IP experience also covers design rights as well as trade marks, passing off, copyright, and breach of contract disputes involving IP
Chairperson, Fifth Board of Appeal
European Union Intellectual Property Office
Gordon Humphreys is currently Chairperson of the First Board and of the Third Board of Appeal
at EUIPO, from 2014 to 2019 he had been Chairperson of the Fifth Board of Appeal, having
joined the Boards as a Member in 2005. He was Head of the Register Service from 2002-2005
and joined EUIPO’s Legal Department in 1997. He is also an accredited mediator with the
Chartered Institute of Arbitrators and is a member of the EUIPO Boards of Appeal Mediation
Service since 2011.
Prior to working at EUIPO, Gordon was in private practice in Luxembourg and Brussels and
qualified both as a barrister (England and Wales) and avocat (Brussels bar). He was also a
member of the CIArb Sub-Committee on Revision of Mediation Rules between 2016 and 2018.
Gordon was educated at the universities of Buckingham (LL.B), Cardiff (LL.M), Liège (masters
in economic law) and Alicante (specialist en derecho de la Unión Europea).
Gordon speaks and writes regularly on ADR, trade mark and design matters, and has recently
co-edited Mediation: Creating Value in International Intellectual Property Disputes, Wolters
Kluwer (2018) and was a contributing author in Hasselblatt, Community Design Regulation:
Article-by-Article Commentary, Second Edition (2018), Beck.
General Manager & Head - Global IP, Product Portfolio and Corporate Strategy
Vice President - IPM
Sr. GM - IPR Legal
Sr. GM - IP Speciality
Dr. Nehal Bhatt has about 18 years of experience of working in the field of Intellectual Property in Pharmaceutical Industry. He is presently working as Senior General Manager, Intellectual property with focus on Speciality Products in Aurobindo Pharma Ltd, Hyderabad. He was associated with companies such as Amneal Pharmaceuticals, Actavis(was Allergan and now Teva), Glenmark Pharmaceuticals and Cadila Pharmaceuticals in past. He has been working in the areas of strategizing non-infringement or invalidity positions and litigation management for different geographies including US, EP and CA, patent filing and prosecution, IP due diligence for mergers and acquisitions, compliance of statutory obligations connected with PIV filings or 505b2 filings in US and MA filings in EU, product identification/selection support to strengthen company’s pipeline.
Dr. Nehal Bhatt is a pharmacy post-graduate from L.M.College of Pharmacy, PhD in Phamaceutical sciences and Post Graduate Diploma in Patent Law. He is a Registered Patent Agent. He has additionally a Diploma in Business Administration from ICFAI
Dr.Reddy’s Laboratories Ltd.
Dr.P.S.R.C.Murthy is presently heading IPR department of Neuland Laboratories Limited, Hyderabad, earlier headed IPR department of Suven Life Sciences Ltd and worked as a Scientist in IPR department of Dr.Reddy’s Laboratories Ltd.
I am having rich, hands-on experience in all aspects of IP. Experience in handling IP for API’s, formulations, NCE’s and Peptides. With experience spanning over 19+ years, myself worked on all major IP concepts like IP creation, IP protection, IP commercialization, IP portfolio management, IP strategy, IP Litigation, IP licensing, Innovation management, Prosecution strategy for patents, creation of patent families for technology picket fencing, Ideation for 505(b)(2) opportunities, Patent drafting, Patent filing, Patent prosecutation, Negotiation and preparation of various IP related agreements, IP training and IPR team building.
Dr.P.S.R.C.Murthy is known as hardcore scientist and inventor, there are over 15 publications including patents, papers and posters.
Intiated and Implemented best IP practices in Dr.Reddy’s, Suven & Neuland Laboratories Ltd resulted lot of awards and saved crores of IP expenditure.
Sr. Director & Head-Business Development
Portfolio & Strategy at Kashiv BioSciences LLC
Dr. Paras Vasanani is presently associated with Kashiv BioSciences LLC (US based innovator pharma company) as Sr. Director & Head Business development, Portfolio & Strategy.
Kashiv is a USA based pharma and biotech company working on Biosimilars, 505b2, NCEs & complex generics. Dr. Paras has started his career as IP professional from Alembic Pharma then Zydus Pharma then Amneal Pharma and currently working at Kashiv BioSciences with vast experience in the area of Intellectual Property Management, portfolio selection and business development activities. He has attended many litigations at US district court & CAFC in person. In the field of IP he has worked for various countries like USA, India, Europe, Canada, Mexico, Brazil and Australia.
Dr. Paras has pursued M.Pharm and Ph.D. with specialization in the field of Pharmaceutical Sciences from M.S.University, Vadodara. He did his MBA from IIM-Ahmedabad. He is registered Indian Patent Agent and Trademark Agent. He has more than 10 patents on his name as inventor. He remained as spoke person at various National & International Conferences, Symposiums and Universities.
Ph.D., Esq. Partner
Greenblum & Bernstein, P.L.C., USA
Paul is a shareholder at G&B, and a member of the Pharmaceutical; Biotechnology; Litigation and Trial; and Client Counseling practice groups of Greenblum & Bernstein. His work in these groups includes preparing and supervising preparation of infringement and validity opinions, Notice Letters, litigation, and FDA citizen petitions, as well as general counseling, particularly in the pharmaceutical, chemical, and medical arts. Paul is involved extensively in the firm's pharmaceutical practice, and advises drug companies (primarily generics) on strategic planning and new product introduction. He works extensively with Hatch-Waxman issues and the interface of patent and FDA law.
Paul is a regular panelist in seminars given in association with the annual conferences of the International Generic Pharmaceutical Association and the European Generics Association and other conferences. Paul is an editor for the Journal of Generic Medicines and regularly contributes articles on patent law and generic drugs.
Paul received a Bachelor of Science in Chemistry with High Honors from the College of William and Mary in 1986, a Ph.D. in Chemistry from the University of Chicago in 1992, and a Juris Doctor degree from the Georgetown University Law Center in 1998. While at Georgetown University, Paul was a staff member of the Journal of Legal Ethics.
Paul is admitted to the Virginia State Bar, the U.S. District Court and Bankruptcy Courts for the District of Columbia, and the Court of Appeals for the Federal Circuit, and is registered to practice before the United States Patent and Trademark Office. Paul is a member of the American Intellectual Property Law Association, the American Bar Association, and the American Chemical Society
Director (Head) - Intellectual Property Management
Fresenius Kabi Oncology Ltd
Dr. Prachi Tiwari is adoctorate in Organic Chemistry, MBA and Law graduate with several PG courses in IPR. She is a registered Indian Patent Agent with about 19 years of experience in leading pharmaceutical companies like Alembic, Ranbaxy (Presently Sun), Teva Pharma and Fresenius Kabi Oncology Ltd.
Dr. Tiwari has more than 16 years of experience as a patent professional and handled a wide sphere of technological areas of patents –chemistry, polymorph, formulations, drug delivery systems, indication, biotechnology & biosimilars and nutrition.
Currently Dr. Prachi is responsible for all the patent matters globally by supporting and advising to the Research & Development, Business and Allied Functions of the Organization. She ensures hassle free product launch and exploring early market entry opportunities by designing around and challenging road block patents/applications. She handles drafting and prosecution of more than 200 patent applications. She is successfully involved in Indian opposition / litigation of Patents/applications. Dr Prachi Tiwari workson identification of new and potential products, for the inclusion in product portfolio grid.
Mankind Pharma Limited
Prateush has a rich corporate experience of 17-years stint with Indian Customs, four years with Viraj Profiles and a further four years with the law firms MV Kini and Co and Kochar and Co. At Indian Customs, where he began his career in 1991, Prateush was instrumental in setting up the first private port and CFs.
At Viraj Profiles Limited, the world’s leading manufacturer of stainless steel long products, Prateush’s portfolio included legal and regulatory matters, taxation, strategy planning, liaising and coordination, statutory compliances, labour matters, contracts, agreements and acquisitions. He was responsible for health checks and internal and statutory audits. He acted as a bridge and point of contact between all supporting functions and businesses for resolving issues and risk mitigation. He liaised with government agencies and ministries at the state and Centre. His tenure with MV Kini and Co and Kochar and Co saw him handling regulatory representation and litigation, providing advice on antidumping matters, statutory compliances and the setting up and de-bonding of SEZ, STPI and EOU.
In his present position as General Counsel, Chief Risk and Compliance Officer at Mankind Pharma Limited, Prateush has been instrumental in the successful closure of all critical litigation. He has also been effective in handling litigation pertaining to a wide range of statutes relating to the pharmaceutical industry as well as Tax, Employment, Corporate and Anti-Trust laws.
Head IP - Product Portfolio
Sr. General Manager & Head – Corporate IP
Piramal Pharma Global
Experience: 26+ years (16+ years in Corporate IP and prior 10 years as research scientist in Medicinal Chemistry)
Senior IP Consultant
Indoco Remedies Ltd
Swati is an accomplished IP expert. In her career spanning over 26 years, she has been involved in strategic patent portfolio management; drafting and prosecuting over 500 world-wide patent applications; providing legal opinions on patentability, patent infringement, FTO analysis and validity issues, and devising strategies for patent litigation.
Currently, in her role as Senior IP Consultant at Indoco Remedies Ltd., Swati provides strategic expertise on a broad range of IP issues, advises senior management on IP issues that have legal implications, prepares opinions and deals with IP litigations. Prior to joining Indoco, Swati served as In-House Patent Counsel and Head of Patents Dept. at Piramal Healthcare Ltd. overlooking protection of inventions in Drug Discovery Research, process chemistry and formulations. During her tenure, Piramal won Pharmexcil “Platinum Patent Award” in 2014, for securing the most number of patents under overall category. She has also worked as patent professional for leading Indian Pharmaceuticals including Sun Pharma. and Lupin.
Swati is a frequent speaker on emerging areas of patent law at various events. Recognised among “Powerful Women in IP - India 2021” by World Intellectual Property Forum. In the year 2019, Swati received recognition as “IP Star Woman of the Year” from Legal Era Magazine. Also, received recognition amongst “Top 100 Powerful Women in Law” by World Intellectual Property Forum in the year 2017.
Vice Prresident and Head Portfolio Planning and IP Litigtaion
Dr. Taranpreet Singh Lamba is presently working as Vice President of Intellectual Property and Product Portfolio Management in Glenmark Pharmaceuticals Limited, Mumbai. He has more than 19years of rich experience in the patent matters with specific focus in managing patent portfolios, infringement analysis and litigations for various geographies like US, EP, India and Emerging Markets. He is also a Head of Product Portfolio in Glenmark for making future pipeline for key regulated markets including US, Europe.
Dr. Taranpreet Singh Lamba is a pharmacy graduate and has done M. Tech in Pharmaceutical Technology from NIPER and has further also done specialization in patent law.
A.V.P. – IPM
Hetero Labs Ltd.
Vijay Nasare is Associate Vice President – IP & Portfolio Management at Hetero Labs Ltd. He is responsible for devising and implementing IP strategies at Hetero. He handles patent litigations and settlement at Hetero and performs key role in developing Hetero’s internal and external pipeline. Prior to joining Hetero, he worked with Glenmark Pharmaceuticals Inc USA, where he was mainly responsible for patent litigation and product launch management. Prior to Glenmark, he worked at Dr Reddy’s Laboratories Ltd and FDC limited. He is Post graduate in Pharmaceutical Sciences and he has earned his Degree of Law from the University of Mumbai. Vijay Nasare has also done PGDM (Executive) from Narsee Monjee institute of Management Studies.